NEWS
- How to Join
- Renew Membership
- News
- Events
- Publications
- Presentations
- Corporate Sponsors
- Associate Members
- Links
SPONSORS
Board of Directors
TBI is governed by a Board of Directors that represent Ontario’s pharmaceutical and biotechnology industry. These elected directors provide guidance and set policy for TBI, facilitating The Biotechnology Intiative’s strong voice in advocacy and economic development in Ontario.
TBI Board of Directors, effective April 2009
|
Allan Odette
Allan is currently the Director of External Relations (Ontario) and National Private Markets for GlaxoSmithKline Canada Inc. His main area of responsibility is to foster globally competitive market access for GSK products and sound investment conditions for GSK in Ontario.
GlaxoSmithKline Canada |
|
Anthony Giovinazzo
Anthony J. Giovinazzo, M.B.A.; C.Dir.; has 31 years of experience in international investment and operating management, with an emphasis in strategy, mergers and acquisitions, financial management and business development. His industry experience includes, biotechnology, investment banking, mining and manufacturing .
Cervelo Pharmaceuticals Ltd. |
|
Bonnie Kuehl
Dr. Bonnie Kuehl is CEO and founder of Scientific Insights® Consulting Group Inc. a scientific and medical research and communications company. Scientific Insights® specializes in the strategic interpretation of scientific, medical and clinical information and technology.
Scientific Insights Consulting Group Inc. |
|
Dale Patterson
Dale Patterson is the President of The Bourton Group, a private, independent marketing, communications and government relations consulting practice.
The Bourton Group |
|
Darlene Homonko
Dr. Homonko became Executive Director of the Golden Horseshoe Bioscience Network (GHBN) in August of 2005.
Golden Horseshoe Venture Forum |
|
Denis Ferkany
Denis brings 30 years experience in senior management, business and product development, and strategic alliances in both private industry and public-private partnerships to the ICAV management team. ICAV is a not-for-profit drug development organization dedicated to the discovery and development of anti-viral therapies for neglected and emerging diseases.
ICAV |
|
Jason Locklin
Jason Locklin is the deputy director of government relations for Canada’s leading vaccine company, Sanofi Pasteur Limited.
Sanofi Pasteur Limited |
|
John Kelly
Dr. John Kelly is the vice-president of innovation and commercialization for the Ontario Fruit & Vegetable Growers’ Association.
Ontario Fruit & Vegetable Growers’ Association |
|
Lorne Meikle
Lorne is well qualified to lead TBI as he has been the CEO of nine companies in the biotechnology area, both in the public arena and private industry.
Management Dynamics Ltd. |
|
Matt Buist
We are Toronto's business advocates and experts. Toronto Economic Development, Culture & Tourism (EDCT) services support and assist existing businesses, potential investors and business associations.
City of Toronto, Office of Economic Dev. |
|
Rob Hamilton
Rob Hamilton is the President of Hamilton & Company, a strategic healthcare consulting firm located in Burlington, Ontario.
Hamilton & Company |
